Evidence map›Paper›PMID 37664110›Full record

ArticleFrontiers in microbiology2023

Novel insights into genetic characteristics of

Yusuke Ota, Isaac Prah, Samiratu Mahazu, Yoshiaki Gu, Yoko Nukui, Ryuji Koike, Ryoichi Saito

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Journal of water and health · 2025
    Article
  3. Article
  4. Tad pili contribute to the virulence and biofilm formation of virulentFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yusuke OtaDepartment of Molecular Microbiology and Immunology, Tokyo Medical and Dental University, Tokyo, Japan.
Isaac PrahDepartment of Molecular Microbiology and Immunology, Tokyo Medical and Dental University, Tokyo, Japan.
Samiratu MahazuDepartment of Molecular Microbiology and Immunology, Tokyo Medical and Dental University, Tokyo, Japan.
Yoshiaki GuDepartment of Infectious Diseases, Tokyo Medical and Dental University, Tokyo, Japan.
Yoko NukuiDepartment of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ryuji KoikeClinical Research Center, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Ryoichi SaitoDepartment of Molecular Microbiology and Immunology, Tokyo Medical and Dental University, Tokyo, Japan.
Tokyo Medical and Dental University · JPKyoto Prefectural University of Medicine · JPTokyo Medical and Dental University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The prevalence of Guiana extended-spectrum (GES)-type carbapenemase producers is increasing worldwide, and hospital water environments are considered as potential reservoirs. However, the genetic features underlying this resistance are not yet fully understood. This study aimed to characterize Methods: Carbapenemase producers were screened using carbapenemase-selective agar and polymerase chain reaction. Whole-genome sequencing analyzes were performed on the carbapenemase-producing isolates. Results: Eleven gram-negative bacteria (four Discussion: The findings on the plasmids and the novel genetic content from a single wastewater sample extend our understanding regarding the diversity of resistance and the associated spread of

Indexed as

GEShospital sewageintegronplasmidtoxin-antitoxin system

Identifiers

PMID37664110
PMCPMC10469963
OpenAlexW4385982729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.